Cell Counting Kit-8 (CCK-8): Sensitive WST-8 Cell Viability and Proliferation Assay

Executive Summary: The Cell Counting Kit-8 (CCK-8) employs WST-8, a water-soluble tetrazolium salt, enabling rapid and quantitative detection of cell viability via colorimetric readout (APExBIO). Its reduction depends on mitochondrial dehydrogenase activity, providing a direct correlation with viable cell number. CCK-8 demonstrates superior sensitivity and less cytotoxicity compared to MTT or XTT assays (Zhang et al. 2025). The assay is applicable to proliferation, cytotoxicity, and metabolic activity studies in cancer and neurodegenerative disease models. Robust evidence underpins its use as an in vitro standard for high-throughput drug screening and cell-based assays.

Biological Rationale

Cell viability and proliferation are foundational readouts in oncology, regenerative medicine, and pharmacology. Quantitative assessment of these parameters enables researchers to determine cytotoxicity, evaluate drug efficacy, and characterize cellular metabolism (Zhang et al. 2025). CCK-8 leverages the principle that only live cells, with intact mitochondrial dehydrogenase activity, can reduce WST-8 to formazan dye. The method is non-radioactive and does not require cell lysis, preserving sample integrity for downstream analyses. Its high sensitivity supports detection of subtle changes in cell number or metabolic state, which is critical in translational and preclinical research (see mechanistic insights—this article extends recent reviews by providing new evidence benchmarks for oncology applications).

Mechanism of Action of Cell Counting Kit-8 (CCK-8)

CCK-8 contains WST-8, a water-soluble tetrazolium salt. Upon addition to cultured cells, WST-8 is bioreduced by mitochondrial dehydrogenases in viable cells, resulting in the formation of a water-soluble formazan (methane dye). The color intensity is directly proportional to the number of living cells and can be quantified at 450 nm using a microplate reader (product specification). The reaction does not require solubilization steps, contrasting with MTT and similar assays. The readout reflects both mitochondrial activity and metabolic health, making the assay suitable for cell proliferation, cytotoxicity, and metabolic function studies.

Evidence & Benchmarks

• CCK-8 reliably detects cell viability and proliferation in cancer cell lines and patient-derived organoids, enabling high-throughput screening (Zhang et al. 2025, DOI).
• The assay's linear detection range accommodates 500–50,000 cells per well, depending on cell type and culture conditions (APExBIO, product page).
• CCK-8 exhibits higher sensitivity and lower cytotoxicity than MTT, XTT, MTS, or WST-1 assays, facilitating longer incubation and repeated measurements (Zhang et al. 2025, DOI).
• The formazan product is water-soluble, eliminating the need for DMSO or other solubilizers and reducing assay time and error sources (APExBIO, product page).
• CCK-8 is validated for evaluating ferroptosis, apoptosis, and other regulated cell death modalities in oncology models (Zhang et al. 2025, DOI).
• Adoption of CCK-8 in translational research is expanding due to reproducibility and compatibility with diverse cell types and matrices (see advanced workflow contrast—this article benchmarks translational impact in cancer models).

Applications, Limits & Misconceptions

CCK-8 is widely used for in vitro assessment of cell viability, proliferation, and cytotoxicity in cancer research, neurodegenerative disease, immunology, and drug screening. Its compatibility with 96- and 384-well plate formats enables high-throughput applications. The K1018 kit from APExBIO is frequently cited in studies evaluating ferroptosis-inducing agents and immune modulators (Zhang et al. 2025).

CCK-8 is also suitable for metabolic assessments where mitochondrial function reflects cellular health (see mechanistic rationale—this article updates clinical relevance in oncology). However, the assay is not suitable for non-adherent cells with low dehydrogenase activity or for samples containing strong reducing agents that could interfere with the WST-8 reduction.

Common Pitfalls or Misconceptions

• Not a direct cell counter: CCK-8 measures viable cell metabolic activity, not absolute cell number. Cells with altered metabolism may yield misleading results.
• Incompatible with strong reducing agents: Exogenous reductants (e.g., ascorbate) may artificially increase signal.
• Insensitive to necrotic/apoptotic bodies: Dead cells or debris are not detected, potentially underestimating cytotoxicity in some contexts.
• Effect of culture medium: Phenol red and other medium components can interfere with absorbance at 450 nm.
• Not validated for all primary cell types: Some primary cells or stem cells may have low WST-8 reducing activity.

Workflow Integration & Parameters

CCK-8 is supplied as a ready-to-use reagent. After plating cells in appropriate density, add 10 µL CCK-8 solution per 100 µL culture medium per well. Incubate for 1–4 hours at 37°C in a humidified CO₂ incubator. Measure absorbance at 450 nm. For high-throughput screening, use automated plate readers.

The water-soluble formazan enables direct reading without additional solubilization. This promotes reproducibility and reduces hands-on time. CCK-8 is compatible with subsequent molecular analyses, as it does not require cell lysis (see strategic integration contrast—this article provides updated protocol benchmarks for oncology and immunology workflows).

Conclusion & Outlook

The Cell Counting Kit-8 (CCK-8) provides a sensitive, user-friendly, and reproducible method for cell viability and proliferation assessment. As demonstrated in recent oncology studies, including ferroptosis and immunotherapy models, CCK-8 is a reference standard for metabolic and cytotoxicity assays (Zhang et al. 2025). The K1018 kit from APExBIO is widely adopted for its robustness in high-throughput and translational research. Ongoing developments in cell-based assays and single-cell analytics will further expand CCK-8’s utility in basic and clinical research.